免费操,国产精品理论片,精品久久久久久久,欧美一级婬妇喷水片,日韩爽爽影院,一区二区日韩国产,竹菊一区二区,亚洲AV成人网在线

<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

Bioactive Sclerostin ELISA Assay Kit from EAGLE BIOSCIENCES INC.

產(chǎn)品貨號(hào)

BI-20472

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

1 x 96 well

產(chǎn)品品牌

EAGLE BIOSCIENCES INC.

產(chǎn)品概述

產(chǎn)品詳情

Edit	&nbsp
Product Name	Bioactive Sclerostin ELISA Assay Kit
Description	This kit is a sandwich enzyme immunoassay for the quantitative determination of bioactive sclerostin in human serum and plasma samples (EDTA, citrate). In a first step, assay buffer is pipetted into the wells of the microtiter strips. Thereafter, STD/sample/CTRL are pipetted into the wells, which are pre-coated with the recombinant human monoclonal Sclerostin antibody. Any bioactive Sclerostin present in the STD/sample/CTRL binds to the pre-coated antibody in the well. After incubation, a washing step is applied where all non-specific unbound material is removed. In a next step, the conjugate (anti sclerostin-HRPO) is pipetted into the wells and reacts with bioactive Sclerostin present in the sample, forming a sandwich. After another washing step, the substrate (TMB Tetramethylbenzidine) is pipetted into the wells. The enzyme catalysed colour change of the substrate is directly proportional to the amount of bioactive sclerostin. This colour change is detectable with a standard microtiter plate ELISA reader. A dose response curve of the absorbance (optical density, OD at 450 nm) versus standard concentration is generated, using the values obtained from the standards. The concentration of bioactive sclerostin in the sample is determined directly from the dose response curve. Sample Types: serum, EDTA plasma, and citrate plasma. Range: 62.5 to 320 pmol/l. Sensitivity: LOD: LOD: (0 pmol/l + 3 SD): 1.9 pmol/l; LLOQ: 1.3 pmol/l. Time: 4 hours ? Sclerostin is a 22.5 kDa secreted glycoprotein that functions as a potent inhibitor of Wnt signaling. It acts by binding to the Wnt-coreceptor LRP5/6 thus inhibiting bone formation by regulating osteoblast function and promoting osteoblast apoptosis. The Sclerostin protein consists of two flexible N- and C-terminal arms and a cystine-knot with three loops, whereas the second loop binds to the LRP5/6 complex (3,4). Sclerostin is classically considered to be a monomeric protein, but data from Hernandez and colleagues (5) postulate that circulating sclerostin has a dimeric configuration. In addition, it is not yet well documented if also Sclerostin fragments circulate, but the comparison of different Sclerostin ELISAs suggest that fragments exist as well.As the epitope of the monoclonal capture antibody utilized in the bioactive Sclerostin ELISA is located in loop 2, the binding region to the LRP 5/6 complex, all Sclerostin molecules (including potential fragments) containing this receptor binding region can be detected.Sclerostin is nearly exclusively produced in osteocytes. Mutations in the Sclerostin (SOST) gene can cause sclerosteosis and van Buchem disease which are bone dysplasia disorders characterized by progressive skeletal overgrowth. Sclerostin levels are altered in response to hormonal stimuli or due to pathophysiological conditions. Sclerostin concentrations are increased in disorders such as hypoparathyroidism, Paget's disease, multiple myeloma and in cancer induced bone diseases. Sclerostin levels are decreased in primary hyperparathyroidism, as well as by the mechanical stimulation of bone. Several studies have found a positive association between sclerostin and bone mineral density. Sclerostin levels in chronic kidney disease (CKD) patients are up to 4-fold increased compared to patients without CKD and increase with CKD stage and declining kidney function. In CKD patients, renal elimination of sclerostin increases with decreasing renal function. In dialysis patients, sclerostin is an independent predictor of bone loss. Numerous studies have shown that serum sclerostin levels are also associated with cardiovascular events. A monoclonal sclerostin antibody for the treatment of osteoporosis is currently undergoing clinical trials. For reviews please see references.
Size	1 x 96 well
Concentration	n/a
Applications	RUO
Other Names	Sclerostin
Gene, Accession, CAS #	n/a
Catalog #	BI-20472
Price
Order / More Info	Bioactive Sclerostin ELISA Assay Kit from EAGLE BIOSCIENCES INC.
Product Specific References	n/a
產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>